Equity facilities for listed issuers

An equity facility is not a home equity line of credit. It is a capital-markets arrangement under which an investor commits to subscribe for newly issued shares of a listed company, on demand, over a fixed term, at a price referenced to the market—the issuer chooses when to draw, how much, and whether to draw at all.

Key takeaways

• The commitment runs one way. The investor is committed to buy; the issuer is not committed to sell, and normally has no minimum drawdown obligation.
• Pricing is market-referenced. Each drawdown prices off a volume-weighted average over a window that opens when the notice is served, so the tape sets the cost, not the terms you signed.
• The resale route is the facility. In the United States the shares are placed privately and resold under a registration statement the SEC staff analyses as an indirect primary offering. No effective statement, no drawdown.
• Three brakes are standard. A floor price, a beneficial ownership blocker (commonly 4.99%, sometimes elective to 9.99%), and an exchange cap below the level that forces a shareholder vote.
• Names are marketing; mechanics are not. Only the pricing window, the caps and the resale route genuinely vary across the four labels.

What an equity facility is, and what it is not

The phrase equity line of credit does most of the damage here. Searched on its own it returns Wells Fargo, Chase and PNC, because to almost everyone it means a second charge secured on a house. The capital-markets structure that borrowed the phrase contains no lending: no principal advanced, no interest, no maturity, nothing to repay. The only thing that travels down the line is newly issued stock, in one direction, when the issuer asks for it.

It is not a revolver either, which commits a lender to advance cash against covenants and counts as liquidity even undrawn. Nor is it an at-the-market programme, where a broker sells already-registered shares into the existing bid for the issuer's account rather than one named investor subscribing at a formula price.

The eight terms that define any facility

Strip the branding away and every facility in this family reduces to the same eight variables.

The four names, and what actually differs

Four labels dominate the documentation, and they map to providers and eras rather than to distinct products. The last two columns are the only places where the name changes what happens to you.

The resale route is the facility

For a US-listed issuer the facility is legally two transactions: a private placement to the investor, and a registered resale by that investor. The staff does not treat that resale as an ordinary secondary offering. Because the issuer holds the put and the investor takes limited market risk, it is analysed as an indirect primary offering conducted through the investor. Corporation Finance Interpretation 139.13, published before the Division renamed its Compliance and Disclosure Interpretations in March 2026 and still cited by many advisers as C&DI 139.13, sets the conditions: a binding agreement in place when the registration statement is filed, a statement "on a form that the company is eligible to use for a primary offering", an existing market evidenced by trading on a national securities exchange or an alternative trading system, and the investor named in the prospectus "as an underwriter, as well as a selling shareholder".

Two consequences issuers miss. Form S-1 satisfies the form-eligibility condition, because any registrant may use it for a primary offering, so an issuer that cannot use a shelf can still register a facility resale; one using a shelf with a public float below US$75 million meets the baby-shelf limit instead. And the pricing formula becomes public the day the statement is filed. There is no such thing as a quiet facility.

Outside the United States there is no resale registration. New shares are admitted to trading under local listing rules, and the binding constraints are the board's authority to allot, any disapplication of pre-emption rights, the prospectus threshold for admitting shares in tranches, and the placement capacity rules that cap issuance without a shareholder vote. Those tests are jurisdiction-specific: see financing a UK or AIM-listed issuer and financing a TSX, TSXV or CSE issuer.

When a facility beats a single placement

A facility earns its place when the requirement is a series of modest amounts across several quarters, when you would rather price against many days of trading than one negotiation with one buyer, and when the amount actually needed is uncertain, because an undrawn facility costs only the fee. It also suits lumpy news flow: drawdowns can be timed after disclosure rather than before it.

A single placement is better when the amount is large relative to average daily traded value, when the use of proceeds is a fixed commitment such as a milestone or a closing obligation, or when the register cannot absorb steady issuance without the price discovering the flow. Look instead at a registered direct offering, a private placement by a public company or a convertible note for a listed issuer. The honest test is arithmetic: divide what you need by median daily traded value and see how many days of the market you would have to be. Then check whether your listing and float qualify, or send the float, the median daily traded value and the drawdown profile.

The four facilities in detail

• All instruments compared
• Resale registration (S-1)
• Dilution and conversion mechanics
• Death spiral financing
• Financing a US-listed issuer

Primary sources

• U.S. Securities and Exchange Commission — Securities Act Sections CFIs, Question 139.13 (private equity line financings)
• eCFR — 17 CFR 230.415, delayed or continuous offering and sale of securities
• U.S. Securities and Exchange Commission — Form S-3 and its General Instructions
• Nasdaq Listing Rules — Rule 5635, shareholder approval

Equity facilities: frequently asked questions

What is an equity facility?

An equity facility is a standing agreement under which an investor commits to subscribe for newly issued shares of a listed company whenever the company serves a drawdown notice, up to an agreed amount and over an agreed term. Each drawdown is priced by reference to the market, usually a volume-weighted average price measured over a window that opens when the notice is served.

Is an equity facility the same as an equity line of credit?

The phrase equity line of credit is used for both, which is why it is worth avoiding. To a consumer it means a home equity line of credit secured on a house. In capital markets it means an equity facility, in which nothing is lent, no interest accrues and nothing is repaid. The only thing that travels down the line is newly issued stock.

Does an issuer have to draw on an equity facility?

In the ordinary case, no. These facilities normally give the issuer control of timing and of the size of each drawdown within the agreed caps, and impose no minimum drawdown obligation. The commitment runs the other way: the investor is bound to fund a compliant notice. Read the specific document, because a facility paired with a pre-paid advance behaves differently.

What stops an equity facility from diluting the register without limit?

Three contractual brakes and one rule. The floor price lets the issuer refuse to sell below a stated level. The beneficial ownership blocker caps what the investor may hold at any moment, commonly 4.99% and sometimes 9.99%. The exchange cap limits total issuance. And the shares registered for resale are themselves a ceiling until a further statement is filed.